Molindone in chronic schizophrenia

Clinical Pharmacology & Therapeutics

Volumn 11, Issue 5, 1970, Pages 680-688

  Clark, Mervin L ^a,b,c   Huber, Wolfgang K ^a,b,c   Sakata, Kenneth ^a,b,c   Fowles, Don C ^a,b,c   Serafetinides, Eustace A ^a,b,c  

^a the Department of Medicine ^*  (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Griffin Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CHOLESTEROL; LIPID; MOLINDONE; PLACEBO; SUGAR; TRIACYLGLYCEROL; INDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; TRANQUILIZER;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTENSION; LIPID BLOOD LEVEL; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; CLINICAL TRIAL; COMPARATIVE STUDY; RATING SCALE;

ADULT; CHLORPROMAZINE; CLINICAL TRIALS; COMPARATIVE STUDY; FEMALE; HUMAN; INDOLES; MALE; MIDDLE AGE; MORPHOLINES; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRANQUILIZING AGENTS;

EID: 0014850243     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt1970115680     Document Type: Article

References (11)